Dupilumab impact on psychiatric and sleep disorder risk reduction in atopic dermatitis: A population-based cohort study

CONCLUSION: Patients with AD prescribed dupilumab exhibited a lower risk of psychiatric and sleep disorders, with the effect being more evident within the Black or African American subgroup.

via https://pubmed.ncbi.nlm.nih.gov/39613228/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20241222010805&v=2.18.0.post9+e462414